Archives

  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Anti-HMGB1 Rabbit Monoclonal Antibody: Technical Use Guide

    2026-05-26

    Anti-HMGB1 Rabbit Monoclonal Antibody: Technical Use Guide

    What This Product Solves

    Detection of High Mobility Group Box 1 (HMGB1) protein is essential in studies of chromatin structure, gene regulation, and cellular signaling. The Anti-HMGB1 Rabbit Monoclonal Antibody (SKU MA3057) provides researchers with an affinity-purified, unconjugated reagent for the detection of HMGB1 in human, mouse, and rat samples. Its specificity and formulation support reproducible results in Western blot, immunohistochemistry (IHC-F and IHC-P), and flow cytometry workflows. This product is strictly intended for research use, where chromatin protein detection and analysis of DNA architecture modulation are required, and is not validated for diagnostic or therapeutic applications.

    For more detailed workflow advice, see the internal article Technical Workflow Guide, which addresses reproducibility concerns in HMGB1 antibody-based assays. Additionally, the Technical Lab Guide discusses research-focused applications and the importance of specific chromatin protein detection.

    Protocol Parameters

    • Assay: Western Blot
      Value: Detects HMGB1 at 25–29 kDa (calculated vs observed)
      Applicability: Human, mouse, and rat samples
      Rationale: Enables identification of HMGB1 within expected molecular weight range for chromatin-associated proteins
      Source Type: Product information
    • Assay: Immunohistochemistry (IHC-F, IHC-P)
      Value: Unconjugated, affinity-purified rabbit IgG
      Applicability: Frozen and paraffin-embedded tissue sections
      Rationale: Suitable for detection of HMGB1 localization in diverse tissue preservation formats
      Source Type: Product information
    • Assay: Flow Cytometry
      Value: Unconjugated (requires secondary antibody for detection)
      Applicability: Single-cell suspension samples from human, mouse, or rat
      Rationale: Allows for HMGB1 quantification in cell populations when paired with appropriate secondary reagents
      Source Type: Product information
    • Assay: Storage
      Value: Store at -20°C; avoid freeze-thaw cycles; shelf life 12 months
      Applicability: All assays; preserves antibody integrity
      Rationale: Maintains antibody activity and reduces degradation risk
      Source Type: Product information
    • Assay: Recommended Antibody Dilution
      Value: Titrate per application and tissue; starting range 1:500–1:2,000 (workflow best practice)
      Applicability: WB, IHC, FC
      Rationale: Optimizes signal-to-noise ratio and reduces background
      Source Type: Workflow recommendation

    Workflow Setup and QC Checklist

    • Confirm antibody lot, concentration, and expiration date prior to use. Only use if within shelf life and stored at -20°C as specified on the product label.
    • Prepare all buffers fresh and ensure compatibility with the antibody formulation (50 mM Tris-Glycine, pH 7.4, containing 0.15 M NaCl, 40% glycerol, 0.01% sodium azide, 0.05% BSA).
    • For Western blot HMGB1 detection, use positive control lysates from HMGB1-expressing cell lines or tissues.
    • In immunohistochemistry HMGB1 experiments, include both negative (no primary antibody) and isotype controls to assess non-specific binding.
    • For flow cytometry HMGB1 antibody workflows, select a compatible fluorophore-conjugated secondary antibody and validate its specificity in a single-stain control.
    • Document all antibody dilutions, incubation times, and detection methods for reproducibility.
    • If freezing aliquots, avoid more than one freeze-thaw cycle to maintain antibody performance.

    Common Failure Modes and Fixes

    • Weak or absent HMGB1 signal: Confirm sample expression of HMGB1, verify antibody storage conditions, and titrate antibody concentration. Ensure secondary antibody is compatible and active.
    • High background in immunohistochemistry: Increase blocking time (e.g., with 5% BSA), reduce antibody concentration, or optimize washing steps. Always use appropriate negative controls.
    • Non-specific bands in Western blot: Optimize lysis conditions, gel percentage, and transfer protocol. Use fresh reducing agents and confirm antibody specificity with isotype controls.
    • Variable results between runs: Standardize sample preparation, antibody incubation times, and detection reagents. Maintain consistent storage and handling of the antibody.
    • Loss of activity after freeze-thaw: Aliquot antibody into single-use volumes to prevent repeated freeze-thaw cycles.

    Scope and Limitations

    The Anti-HMGB1 Rabbit Monoclonal Antibody is designed for the specific detection of HMGB1 in research samples from human, mouse, and rat sources. Its validated applications are limited to Western blot, immunohistochemistry (both frozen and paraffin-embedded tissues), and flow cytometry. It is unconjugated and should be paired with appropriate secondary antibodies when fluorescence or chemiluminescent detection is required. This reagent is not suitable for diagnostic or therapeutic use, nor is it validated for applications outside the stated scope (e.g., ELISA, immunoprecipitation) unless further optimization is performed by the user. Researchers should be aware that species cross-reactivity is limited to those specified, and performance may vary in non-validated sample types or conditions. For protocol-specific troubleshooting, consult internal technical guides or the APExBIO product page.

    Conclusion

    The Anti-HMGB1 Rabbit Monoclonal Antibody (SKU MA3057) provides a robust and specific option for HMGB1 detection in established research assays. By adhering to recommended storage, handling, and workflow protocols, users can achieve reproducible results in chromatin protein detection projects. For researchers requiring additional technical context or troubleshooting, internal workflow and lab guides are available and directly relate to optimizing antibody-based HMGB1 detection.